Evidence map›Paper›PMID 31467147›Full record

ArticleRNA (New York, N.Y.)2019

Evidence that the

Sarah N Malkowski, Tara C J Spencer, Ronald R Breaker

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. The current riboswitch landscape inMicrobiology (Reading, England) · 2024
    Review
  4. Article
  5. Article
  6. Full-Length NADBiochemistry · 2023
    Article
  7. Riboswitches, from cognition to transformation.Synthetic and systems biotechnology · 2023
    Review
  8. Article
  9. Discovering riboswitches: the past and the future.Trends in biochemical sciences · 2023
    Review
  10. Article
  11. Variants of the guanine riboswitch class exhibit altered ligand specificities for xanthine, guanine, or 2'-deoxyguanosine.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Construction of an Alternative NADAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sarah N MalkowskiDepartment of Chemistry, Yale University, New Haven, Connecticut 06520-8103, USA.ORCID 0000-0002-9644-6917
Tara C J SpencerDepartment of Biology, Howard University, Washington, D.C. 20059, USA.ORCID 0000-0003-4056-8728
Ronald R BreakerDepartment of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520-8103, USA.ORCID 0000-0002-2165-536X
Howard Hughes Medical Institute · USHoward University · USYale University · US

Funding

X-RAY ANALYSIS OF PROTEIN STRUCTURE AND FUNCTIONP01GM022778 · NIGMS · YALE UNIVERSITY · PI BREAKER, RONALD R · 1985 to 2019
$26.1M
Howard Hughes Medical InstituteNIGMS NIH HHS P01 GM022778
6 · The paper itself

Abstract

The

Indexed as

RiboswitchAdenosine DiphosphateAlkyl and Aryl TransferasesBacteriaComputational BiologyLigandsNADNucleic Acid ConformationNucleotide MotifsRNA, MessengerAdenosine DiphosphateAlkyl and Aryl TransferasesLigandsNADRiboswitchRNA, Messengeradenosine-5'-diphosphateaptamergene controlnicotinamide adenine dinucleotidenoncoding RNA

Identifiers

PMID31467147
PMCPMC6859854
OpenAlexW2970139670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.